Lineage Cell Therapeutics, Inc. reports

Company location: Carlsbad, CA
Fiscal year end: 31 December

Lineage Cell Therapeutics, Inc. has filed 1,802 SEC EDGAR filings since 17 Apr 1996

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 526-550 of 1,000 matching filings.

Per page

Current page

10-K/A File 001-12830

BIOTIME, INC 10-K A 12-31-2016

Filing date: 29 Mar 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

BIOTIME, INC. 8-K

Filing date: 28 Mar 2017
Reporting date: 16 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-12830

BIOTIME, INC 10-K 12-31-2016

Filing date: 16 Mar 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-12830

BIOTIME, INC. 8-K

Filing date: 16 Mar 2017
Reporting date: 16 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

BIOTIME, INC 8-K 2-17-2017

Filing date: 21 Feb 2017
Reporting date: 17 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-42290

SC 13D/A filing

Filing date: 17 Feb 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

OWNERSHIP DOCUMENT

Filing date: 17 Feb 2017
Reporting date: 15 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 3 SUBMISSION

Filing date: 15 Feb 2017
Reporting date: 06 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

BIOTIME, INC 8-K 2-15-2017

Filing date: 15 Feb 2017
Reporting date: 15 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 5 SUBMISSION

Filing date: 14 Feb 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

BIOTIME, INC 8-K 2-10-2017

Filing date: 13 Feb 2017
Reporting date: 10 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-201824

424B5

Filing date: 10 Feb 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

BIOTIME, INC 8-K 2-9-2017

Filing date: 09 Feb 2017
Reporting date: 09 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-201824

424B5

Filing date: 09 Feb 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-42290

ALFRED D KINGSLEY SC 13DA NO 33 1-3-2017 (BIOTIME INC)

Filing date: 10 Jan 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 06 Jan 2017
Reporting date: 03 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 06 Jan 2017
Reporting date: 03 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 5 SUBMISSION

Filing date: 06 Jan 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 5 SUBMISSION

Filing date: 06 Jan 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

3/A

FORM 3/A SUBMISSION

Filing date: 15 Dec 2016
Reporting date: 19 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 18 Nov 2016
Reporting date: 19 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 3 SUBMISSION

Filing date: 16 Nov 2016
Reporting date: 19 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-12830

BIOTIME, INC. 10-Q 9-30-2016

Filing date: 04 Nov 2016
Reporting date: 30 Sep 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-12830

BIOTIME, INC. 8-K

Filing date: 03 Nov 2016
Reporting date: 03 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

BIOTIME INC. 8-K 9-8-2016

Filing date: 14 Sep 2016
Reporting date: 08 Sep 2016
SEC evidence: Open document Open filing
Next action: Verify source filing